ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026
GABAergic neurons in the ventrolateral periaqueductal gray mediate fentanyl withdrawal and self-administration in mice.
Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Opioid addiction is characterized by compulsive drug seeking and use, accompanied by pain and heightened pain sensitivity (hyperalgesia) during withdrawal, yet the underlying neural mechanisms remain incompletely understood, especially for fentanyl. Using whole-brain Fos mapping and network analysis, we found that the periaqueductal gray is a central hub brain region engaged during fentanyl withdrawal, suggesting a prominent role for this region in withdrawal-associated neural signaling and warranting further examination. The ventrolateral periaqueductal gray (vlPAG) is a key site for nociceptive processing and shows robust neuronal responses during opioid withdrawal, but the role of its GABAergic neurons in fentanyl withdrawal has not been defined, and their contribution to the self-administration of drugs has not been investigated. We combined behavioral, molecular, electrophysiological, and chemogenetic approaches to examine the role of GABAergic vlPAG neurons during fentanyl withdrawal, and their contribution to withdrawal-induced hyperalgesia and fentanyl intake. During withdrawal from fentanyl, we observed increased Fos expression in GABAergic vlPAG neurons and enhanced inhibitory synaptic transmission revealed by channelrhodopsin-assisted circuit mapping, indicating increased GABAergic neuronal activity and inhibitory synaptic activity due to fentanyl use and withdrawal. Chemogenetic inhibition of GABAergic vlPAG neurons alleviated withdrawal-induced hyperalgesia. Male control mice exhibited overall escalating fentanyl self-administration across the final four intravenous self-administration sessions, whereas this escalation was not observed in males whose GABAergic vlPAG neurons were inhibited. Female mice did not exhibit a comparable effect. Together, these findings demonstrate that GABAergic vlPAG neurons are recruited during fentanyl withdrawal and contribute to withdrawal-associated nociceptive hypersensitivity. In addition, modulation of this population affects fentanyl self-administration in a sex-dependent manner. Targeting inhibitory signaling within the vlPAG may represent a strategy to alleviate withdrawal-associated hyperalgesia and limit fentanyl use.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.